Altered detrusor contractility in MPTP-treated common marmosets with bladder hyperreflexia

PloS One
Sara PritchardMahmoud M Iravani

Abstract

Bladder hyperreflexia is a common non-motor feature of Parkinson's disease. We now report on the contractility of the isolated primate detrusor strips devoid of nerve input and show that following MPTP, the amplitude and frequency of spontaneous contraction was increased. These responses were unaffected by dopamine D1 and D2 receptor agonists A77636 and ropinirole respectively. Contractions by exogenous carbachol, histamine or ATP were similar and no differences in the magnitude of noradrenaline-induced relaxation were seen in detrusor strip obtained from normal and MPTP-treated common marmosets (Callithrix jacchus). However, the neurogenic contractions following electrical field stimulation of the intrinsic nerves (EFS) were markedly greater in strips obtained from MPTP treated animals. EFS evoked non-cholinergic contractions following atropine were also greater but the contribution of the cholinergic innervation as a proportion of the overall contraction was smaller in the detrusor strips of MPTP treated animals, suggesting a preferential enhancement of the non-cholinergic transmission. Although dopaminergic mechanism has been proposed to underlie bladder hyperreflexia in MPTP-treated animals with intact bladder, the present ...Continue Reading

References

Mar 1, 1990·The Journal of Pharmacy and Pharmacology·G N Luheshi, M A Zar
Apr 1, 1990·The Journal of Urology·M A ZarG N Luheshi
Apr 22, 1988·Neuroscience Letters·A AlbaneseJ D Stephenson
May 1, 1986·Journal of Neurology, Neurosurgery, and Psychiatry·R KirbyR Bannister
Dec 1, 1985·British Journal of Urology·H FitzmauriceR T Turner-Warwick
Dec 1, 1982·The Journal of Urology·C SjögrenB Moller-Madsen
Jun 1, 1996·The Journal of Urology·B H ChungK C Chang
Mar 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·L SmithC D Marsden
May 30, 1998·British Journal of Pharmacology·G McMurrayA F Brading
Jan 3, 2001·Neurourology and Urodynamics·S SekiK E Andersson
Dec 17, 2004·Pharmacological Reviews·Karl-Erik Andersson, Alan J Wein
Oct 26, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K WingeH Stimpel
Feb 9, 2006·Journal of Neurochemistry·Mahmoud M IravaniAnthony H Schapira
Feb 9, 2006·British Journal of Pharmacology·William C de Groat
Feb 21, 2006·Lancet Neurology·K Ray ChaudhuriUNKNOWN National Institute for Clinical Excellence
Apr 12, 2006·Nature Clinical Practice. Urology·Michael R Ruggieri
May 14, 2008·Parkinsonism & Related Disorders·Helen BlackettBrian Wood
Jul 1, 2010·Neurourology and Urodynamics·Roberto SolerKarl-Erik Andersson
Oct 22, 2011·Neurobiology of Disease·Ryuji SakakibaraTatsuya Yamamoto
May 3, 2012·Neurobiology of Disease·Penelope J HallettOle Isacson
Nov 23, 2013·Purinergic Signalling·Geoffrey Burnstock

❮ Previous
Next ❯

Citations

Sep 11, 2020·International Journal of Molecular Sciences·Takeya KittaNobuo Shinohara
Jan 4, 2019·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Jeanette M Metzger, Marina E Emborg

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

Prism

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.